Source:http://linkedlifedata.com/resource/pubmed/id/20451506
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2010-7-8
|
pubmed:abstractText |
We have reported the neuroprotective effects of pre-treatment with beta-adrenoceptor antagonists on the cerebral infarction at 1 and 7 days after focal ischemia in rats. However, the protective effect of post-treatment with beta-adrenoceptor antagonists has not been investigated yet. This study was conducted to evaluate the post-treatment effects of selective beta(1)-adrenoceptor antagonists in the rat focal cerebral ischemia. Halothane anesthetized, normothermic adult male Sprague-Dawley rats were subjected to 2h of middle cerebral artery occlusion (MCAO) using the intraluminal suture technique confirmed by laser Doppler flowmetry. Rats received intravenous infusion of saline 0.5 mL/h, esmolol 200 microg/kg/min, or landiolol 50 microg/kg/min (n=8 in each group). Infusion was initiated 30 min after MCAO and continued for 24h. Rats were allowed to survive for 7 days, and the neurological deficit score was evaluated at 1, 4 and 7 days after reperfusion. The brains were removed and stained with triphenyltetrazolium chloride at 7 days after reperfusion. Neurological deficit scores were lower in the rats treated with esmolol or landiolol, compared with saline-treated rats at 1 day as well as 4 and 7 days. The infarct volumes of cortical and striatum were less in the rats receiving beta-adrenoceptor antagonists than in saline-treated rats (P<0.05). The current study indicates that administration of selective beta1-adrenoceptor antagonists after the onset of ischemia also improved neurological and histological outcomes following transient focal cerebral ischemia in rats.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Morpholines,
http://linkedlifedata.com/resource/pubmed/chemical/Neuroprotective Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Propanolamines,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic, beta-1,
http://linkedlifedata.com/resource/pubmed/chemical/Urea,
http://linkedlifedata.com/resource/pubmed/chemical/esmolol,
http://linkedlifedata.com/resource/pubmed/chemical/landiolol
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1872-6240
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright (c) 2010 Elsevier B.V. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
9
|
pubmed:volume |
1343
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
213-7
|
pubmed:meshHeading |
pubmed-meshheading:20451506-Adrenergic beta-Antagonists,
pubmed-meshheading:20451506-Animals,
pubmed-meshheading:20451506-Brain Infarction,
pubmed-meshheading:20451506-Brain Ischemia,
pubmed-meshheading:20451506-Disease Models, Animal,
pubmed-meshheading:20451506-Male,
pubmed-meshheading:20451506-Morpholines,
pubmed-meshheading:20451506-Nerve Degeneration,
pubmed-meshheading:20451506-Neuroprotective Agents,
pubmed-meshheading:20451506-Propanolamines,
pubmed-meshheading:20451506-Rats,
pubmed-meshheading:20451506-Rats, Sprague-Dawley,
pubmed-meshheading:20451506-Receptors, Adrenergic, beta-1,
pubmed-meshheading:20451506-Treatment Outcome,
pubmed-meshheading:20451506-Urea
|
pubmed:year |
2010
|
pubmed:articleTitle |
Post-treatment with selective ?1 adrenoceptor antagonists provides neuroprotection against transient focal ischemia in rats.
|
pubmed:affiliation |
Department of Anesthesia and Intensive Care Medicine, Akita University Graduate School of Medicine, Akita, Japan. tgoyagi@doc.med.akita-u.ac.jp
|
pubmed:publicationType |
Journal Article
|